• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet.

作者信息

Collado Anna, Boaro Maria Paola, van der Veen Sigrid, Idrizovic Amira, Biemond Bart J, Beneitez Pastor David, Ortuño Ana, Cela Elena, Ruiz-Llobet Anna, Bartolucci Pablo, de Montalembert Marianne, Castellani Gastone, Biondi Riccardo, Manara Renzo, Sanavia Tiziana, Fariselli Piero, Kountouris Petros, Kleanthous Marina, Alvarez Federico, Zazo Santiago, Colombatti Raffaella, van Beers Eduard J, Mañú-Pereira María Del Mar

机构信息

Service of Pediatric Hematology, Hospital Universitari Vall d'Hebrón, ERN-EuroBloodNet member, Barcelona, Spain.

Rare Anemia Disorders Research Laboratory, Cancer and Blood Disorders in Children, Vall d'Hebrón Institut de Recerca, Barcelona, Spain.

出版信息

Hemasphere. 2023 Feb 22;7(3):e844. doi: 10.1097/HS9.0000000000000844. eCollection 2023 Mar.

DOI:10.1097/HS9.0000000000000844
PMID:36844183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9949761/
Abstract
摘要

相似文献

1
Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet.镰状细胞病精准医学的挑战与机遇：GenoMed4All联盟和ERN - 欧洲血液网的欧洲新方法
Hemasphere. 2023 Feb 22;7(3):e844. doi: 10.1097/HS9.0000000000000844. eCollection 2023 Mar.
2
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.镰状细胞病在欧盟的现状和挑战：欧洲罕见病网络-欧洲血液网的观点。
Lancet Haematol. 2023 Aug;10(8):e687-e694. doi: 10.1016/S2352-3026(23)00182-5. Epub 2023 Jul 11.
3
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey.欧洲镰状细胞病患儿经颅多普勒筛查和卒中预防机会有限：一项多国 EuroBloodNet 调查结果。
Pediatr Blood Cancer. 2024 Oct;71(10):e31190. doi: 10.1002/pbc.31190. Epub 2024 Jul 10.
4
Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience.镰状细胞病：将患者参与融入国际会议可以改变患者经验的作用。
Orphanet J Rare Dis. 2023 Nov 1;18(1):341. doi: 10.1186/s13023-023-02951-8.
5
Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities.后基因组时代的中医药研究：良好实践、重点、挑战和机遇。
J Ethnopharmacol. 2012 Apr 10;140(3):458-68. doi: 10.1016/j.jep.2012.02.028. Epub 2012 Feb 23.
6
Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.罕见肝脏疾病的医疗服务获取：欧洲参考网络（ERN）罕见肝脏疾病的进展。
Orphanet J Rare Dis. 2019 Jul 8;14(1):169. doi: 10.1186/s13023-019-1152-z.
7
Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia.欧洲血液学协会（EHA）与欧洲血液网关于高铁血红蛋白血症诊断与治疗的联合建议摘要
Hemasphere. 2021 Nov 17;5(12):e660. doi: 10.1097/HS9.0000000000000660. eCollection 2021 Dec.
8
Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.药物不良反应背景下的药物基因组学与全球精准医学：未来十年的十大机遇与挑战
OMICS. 2016 Oct;20(10):593-603. doi: 10.1089/omi.2016.0122. Epub 2016 Sep 19.
9
Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).明确镰状细胞病干预措施：镰状细胞病实施联盟（SCDIC）的一项研究方案
BMC Health Serv Res. 2018 Jun 27;18(1):500. doi: 10.1186/s12913-018-3297-1.
10
European Reference Networks: challenges and opportunities.欧洲参考网络：挑战与机遇。
J Community Genet. 2021 Apr;12(2):217-229. doi: 10.1007/s12687-021-00521-8. Epub 2021 Mar 17.

引用本文的文献

1
Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.为基于基因添加或基因编辑的治疗方法选择镰状细胞病患者：代表欧洲血液学协会（EHA）专门工作组和欧洲血液与骨髓移植协会（EBMT）血红蛋白病工作组联合共识会议撰写的报告
Hemasphere. 2025 Mar 13;9(3):e70089. doi: 10.1002/hem3.70089. eCollection 2025 Mar.
2
Special Issue "Personalized Medicine in Blood Disease of Children".特刊“儿童血液病中的个性化医疗”。
J Pers Med. 2024 Mar 5;14(3):285. doi: 10.3390/jpm14030285.

本文引用的文献

1
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey.欧洲镰状细胞病患儿经颅多普勒筛查和卒中预防机会有限：一项多国 EuroBloodNet 调查结果。
Pediatr Blood Cancer. 2024 Oct;71(10):e31190. doi: 10.1002/pbc.31190. Epub 2024 Jul 10.
2
Precision Medicine and Sickle Cell Disease.精准医学与镰状细胞病
Hemasphere. 2022 Aug 18;6(9):e762. doi: 10.1097/HS9.0000000000000762. eCollection 2022 Sep.
3
Metabolomic and molecular insights into sickle cell disease and innovative therapies.代谢组学和分子生物学对镰状细胞病和创新疗法的研究进展
Blood Adv. 2019 Apr 23;3(8):1347-1355. doi: 10.1182/bloodadvances.2018030619.
4
Genotype imputation performance of three reference panels using African ancestry individuals.三种参考面板在非洲血统个体中的基因型推断性能。
Hum Genet. 2018 Apr;137(4):281-292. doi: 10.1007/s00439-018-1881-4. Epub 2018 Apr 10.